Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acasti, Aim, Amarin, Astellas, Caribou, Gennova, Hutchmed, Pfizer, Phathom, Scisparc, Seagen, Shionogi.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelrx, Aeterna, Alora, Anagram, Biomed X, Biotheryx, Cyclerion, Dr. Reddy’s, Eagle, Ginkgo, Incyte, Liminal, Merck KGaA, Scilex, Sorrento, Stridebio.
New hires and promotions in the biopharma industry, including: Biorchestra, Clearside, Clexbio, Generation, Rocket, Sisaf, Sparingvision, Surrozen, Walden.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Aim Immunotech, Astellas, Brim, Edesa, Everest Medicines, Gennova, Hutchmed, Inflarx, Seagen, Shionogi.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Athos, Huidagene, Hutchmed, Immvira, Incyte, Samsung Bioepis, Transcenta.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen Medical, Bioxytran, Dxvx C., Eisai, Immutep, Invivyd, Kintor, Olix, Takeda, Vacmedix UK, Yishengbio.